| 000 | 01698 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517102046.0 | ||
| 264 | 0 | _c20180806 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1471-6771 | ||
| 024 | 7 |
_a10.1093/bja/aew151 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDistelmaier, K | |
| 245 | 0 | 0 |
_aBeneficial effects of levosimendan on survival in patients undergoing extracorporeal membrane oxygenation after cardiovascular surgery. _h[electronic resource] |
| 260 |
_bBritish journal of anaesthesia _c07 2016 |
||
| 300 |
_a52-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCardiovascular Surgical Procedures |
| 650 | 0 | 4 | _aExtracorporeal Membrane Oxygenation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrazones _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
| 650 | 0 | 4 |
_aPyridazines _xtherapeutic use |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aSimendan |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRoth, C | |
| 700 | 1 | _aSchrutka, L | |
| 700 | 1 | _aBinder, C | |
| 700 | 1 | _aSteinlechner, B | |
| 700 | 1 | _aHeinz, G | |
| 700 | 1 | _aLang, I M | |
| 700 | 1 | _aMaurer, G | |
| 700 | 1 | _aKoinig, H | |
| 700 | 1 | _aNiessner, A | |
| 700 | 1 | _aHülsmann, M | |
| 700 | 1 | _aSpeidl, W | |
| 700 | 1 | _aGoliasch, G | |
| 773 | 0 |
_tBritish journal of anaesthesia _gvol. 117 _gno. 1 _gp. 52-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/bja/aew151 _zAvailable from publisher's website |
| 999 |
_c26137867 _d26137867 |
||